ResMed (RMD) Tops Q2 EPS by 11c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.55 +0.42%
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +6.9%
Financial Fact:
Gross profit: 269.18M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $2.43, $0.11 better than the analyst estimate of $2.32. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean Nears Deal For Sandals - FT
- Bessent emerging as a frontrunner for U.S. President Donald Trump’s new “AI czar” position - Semafor
- First Solar (FSLR) PT Lowered to $250 at GLJ Research
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
